404
+1-313-307-4176
Clinical Mass Spectrometry Market Report
Global Clinical Mass Spectrometry Market, Dynamics, Trends, and Market Analysis
The report on Global Clinical Mass Spectrometry Market is segmented by Product (Gas chromatography-mass spectrometry, Liquid chromatography–mass spectrometry, Maldi TOF mass spectrometer, Capillary electrophoresis–mass spectrometry, Ion mobility spectrometry-mass spectrometry), By Application (Drug Discovery, Clinical Testing, Proteomics), By End-Use (Hospitals, Diagnostic Centers, Research Laboratories) and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global clinical mass spectrometry market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The Global Clinical Mass Spectrometry Market is projected to grow from USD 785.6 million in 2020 to USD 1,242.3 million by 2026 at a CAGR of over 7.9% during the forecast period.
Wish to get a scope on this report? Click here to get a free sample.
Clinical mass spectrometry is extensively accepted in specialized clinical laboratories and research labs, and its adoption is substantially growing in routine laboratories. The combination of mass spectrometry with liquid chromatography (LC) or gas chromatography (GC) has contributed to the rapid expansion of this technology. Mass spectrometry has widespread application in many clinical areas such as therapeutic drug monitoring, clinical toxicology, and drugs of abuse.
Key players operating in the global clinical mass spectrometry market are-
The global clinical mass spectrometry market is likely to be driven by a rapid increase in technological developments in spectrometry, advancement of healthcare technologies, and growing R&D investments.
Further, growing developments in the developing countries, as well as grants & funds provided by the government organizations, provide lucrative growth opportunities to the market players. However, the capital investment associated with the maintenance and installation of these devices is likely to impede market growth.
Based on application, the global clinical mass spectrometry market has been categorized into drug discovery, clinical testing, and proteomics.
By region, the market in North America witnessed the highest market share in 2020 and is projected to grow at a robust CAGR during the review period.
The ongoing COVID-19 pandemic has positively influenced the clinical mass spectrometry industry.
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The clinical mass spectrometry market size is expected to reach USD 1,242.3 million in the coming years.
Bruker (The U.S), Thermo Fisher Scientific Inc. (The U.S), Danaher (The U.S), Agilent Technologies (The U.S), PerkinElmer Inc. (The U.S), Shimadzu Corporation (Japan), Kore Technologies (India), BME Bergmann (Netherlands), Mass Spectrometry Instruments (The U.S) and Photonics GmbH (The U.S) are among the key players in the clinical mass spectrometry market.
The clinical mass spectrometry market is expected to witness an impressive growth of 7.9% CAGR in the foreseeable future.
North America witnessed the highest market share in 2020 and is projected to grow at a robust CAGR.
The clinical testing segment garnered the highest market share in 2020 and is likely to register a healthy CAGR.
Rapid increase in technological developments in spectrometry, advancement of healthcare technologies, and growing R&D investments are the factors driving the growth of clinical mass spectrometry market.
Clinical mass spectrometry companies, Hospitals, Diagnostic centers and laboratories, Academic Institutions, Research centers & organizations are the target audience in the clinical mass spectrometry market.
WE ACCEPT
